Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Import from EEU Countries to Russia (March 2018)

Saturday, April 28, 2018

Between January and March 2018, Russia imported 2.7 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices, VAT included), which is in monetary terms 42.8% higher than that of the same period of 2017. In physical terms, the import amounted to 40.5 mln units, which is 22.7% lower than that of the same period of 2017.

In March 2018, Russia imported 1.73 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices, VAT included), which is in monetary terms 220% higher than that of March 2017. In physical terms, it is 17.9 mln units, which is 25.2% lower than that of March 2017.

As of March 2018, the absolute leader in monetary terms is Kelun-Kazpharm (Kazakhstan), which accounts for 39% of the total import. Its import has increased b 4.5 times over the year. It is followed by Belmedpreparaty and Borimed (Belarus), with 27% and 18% of the total import.

Chimpharm (Kazakhstan) has the best dynamics, with a 20.5 times increase. The total import from Kazakhstan to Russia has risen by 5 times since January 2018.

Metronidazolum is the most imported drug, it accounts for nearly 18% of the import in monetary terms and has the best dynamics. It is followed by Ciprofloxacinum (16.4%), Both Metronidazolum and Ciprofloxacinum are mainly imported by Kelun-Kazpharm. In physical terms, the leader is Cyanocobalamin, with a 2 times increase over the year. It is imported by Yerevan Chemical and Pharmaceutical Company, its import to Russia has increased by 15 times over the year.

Read more about pharmaceutical drug import from EEU countries to Russia (in 2017) here: http://rncph.com/news/05_04_2018

Volume and dynamics of pharmaceutical drug import from EUU countries to Russia (wholesale prices, VAT included) (2016 – 2017, Q1 2018)

Share: